Calcific aortic stenosis
BR Lindman, MA Clavel, P Mathieu, B Iung… - Nature reviews Disease …, 2016 - nature.com
Calcific aortic stenosis (AS) is the most prevalent heart valve disorder in developed
countries. It is characterized by progressive fibro-calcific remodelling and thickening of the …
countries. It is characterized by progressive fibro-calcific remodelling and thickening of the …
Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?
S Windecker, T Okuno, A Unbehaun… - European heart …, 2022 - academic.oup.com
Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research
VARC-3 Writing Committee, P Généreux… - European heart …, 2021 - academic.oup.com
Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …
Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement: a report from the American Society of Echocardiography …
WA Zoghbi, FM Asch, C Bruce, LD Gillam… - Journal of the American …, 2019 - Elsevier
Valvular disease remains a major cause of cardiovascular morbidity and mortality
worldwide. 1 Over the past decade, catheter-based interventions in valvular disease have …
worldwide. 1 Over the past decade, catheter-based interventions in valvular disease have …
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a …
MJ Mack, MB Leon, CR Smith, DC Miller, JW Moses… - The Lancet, 2015 - thelancet.com
Summary Background The Placement of Aortic Transcatheter Valves (PARTNER) trial
showed that mortality at 1 year, 2 years, and 3 years is much the same with transcatheter …
showed that mortality at 1 year, 2 years, and 3 years is much the same with transcatheter …
Transcatheter aortic-valve replacement with a self-expanding prosthesis
DH Adams, JJ Popma, MJ Reardon… - … England Journal of …, 2014 - Mass Medical Soc
Background We compared transcatheter aortic-valve replacement (TAVR), using a self-
expanding transcatheter aortic-valve bioprosthesis, with surgical aortic-valve replacement in …
expanding transcatheter aortic-valve bioprosthesis, with surgical aortic-valve replacement in …
Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis
Background: Transcatheter aortic valve replacement (TAVR) is being increasingly performed
in patients with bicuspid aortic valve stenosis (AS). Objectives: This study sought to compare …
in patients with bicuspid aortic valve stenosis (AS). Objectives: This study sought to compare …
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery
JJ Popma, DH Adams, MJ Reardon, SJ Yakubov… - Journal of the American …, 2014 - jacc.org
Objectives: This study sought to evaluate the safety and efficacy of the CoreValve
transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients at …
transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients at …
Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: SCOPE 2 randomized …
C Tamburino, S Bleiziffer, H Thiele, S Scholtz… - Circulation, 2020 - Am Heart Assoc
Background: Few randomized trials have compared bioprostheses for transcatheter aortic
valve replacement, and no trials have compared bioprostheses with supra-annular design …
valve replacement, and no trials have compared bioprostheses with supra-annular design …
Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical …
HGH Thyregod, DA Steinbrüchel, N Ihlemann… - Journal of the American …, 2015 - jacc.org
Background: Transcatheter aortic valve replacement (TAVR) is an option in certain high-risk
surgical patients with severe aortic valve stenosis. It is unknown whether TAVR can be …
surgical patients with severe aortic valve stenosis. It is unknown whether TAVR can be …